Cargando…

254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health

Detalles Bibliográficos
Autores principales: Sakon, C., Vogt, H., Brown, C., Tillman, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527869/
http://dx.doi.org/10.1016/S1569-1993(22)00944-4
_version_ 1784801168999841792
author Sakon, C.
Vogt, H.
Brown, C.
Tillman, E.
author_facet Sakon, C.
Vogt, H.
Brown, C.
Tillman, E.
author_sort Sakon, C.
collection PubMed
description
format Online
Article
Text
id pubmed-9527869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-95278692022-10-03 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health Sakon, C. Vogt, H. Brown, C. Tillman, E. J Cyst Fibros Posters European Cystic Fibrosis Society. 2022-10 2022-10-03 /pmc/articles/PMC9527869/ http://dx.doi.org/10.1016/S1569-1993(22)00944-4 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
Sakon, C.
Vogt, H.
Brown, C.
Tillman, E.
254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title_full 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title_fullStr 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title_full_unstemmed 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title_short 254 Patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the COVID-19 pandemic on physical and mental health
title_sort 254 patient perception of the impact of elexacaftor/tezacaftor/ivacaftor and the covid-19 pandemic on physical and mental health
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527869/
http://dx.doi.org/10.1016/S1569-1993(22)00944-4
work_keys_str_mv AT sakonc 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth
AT vogth 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth
AT brownc 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth
AT tillmane 254patientperceptionoftheimpactofelexacaftortezacaftorivacaftorandthecovid19pandemiconphysicalandmentalhealth